REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 18th, 2009 • Novelos Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 18th, 2009 Company Industry JurisdictionThis Registration Rights Agreement (the “Agreement”) is made and entered into as of this 11th day of February, 2009 by and among Novelos Therapeutics, Inc., a Delaware corporation (the “Company”), Purdue Pharma L.P., a Delaware limited partnership (“Purdue”), the “Series D Investors” named in that certain Securities Purchase Agreement, dated March 26, 2008, as amended on April 9, 2008, by and among the Company and the Series D Investors (the “Series D Securities Purchase Agreement”), and the holders of the Series B Warrants (as defined below) (the Company, Purdue, the Series D Investors and the holders of the Series B Warrants are sometimes referred to herein individually as “Party” and collectively as the “Parties”). Capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Series E Securities Purchase Agreement.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 14th, 2008 • Novelos Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 14th, 2008 Company Industry JurisdictionThis Registration Rights Agreement (the “Agreement”) is made and entered into as of this 11th day of April, 2008 by and among Novelos Therapeutics, Inc., a Delaware corporation (the “Company”), the “Investors” named in that certain Securities Purchase Agreement, dated March 26, 2008, as amended on April 9, 2008, by and among the Company and the Investors (the “Securities Purchase Agreement”), and the holders of the Series B Warrants (as defined below). Capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Securities Purchase Agreement.